Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Tumor
1000-7431
2005 Issue 5
jian xun
..............page:470,503,509,515
yi ti wei bu shen jing nei fen mi ai he bing wei zuo mo xiang guan lin ba liu yi li
tang wen zuo ; yuan zu rong ; tang jian xiong ; wang wei ; tu yan yuan
..............page:516-516
wei chang jian zhi liu : cong kit dao ge lie wei
wang ning ; wang bin ; wang ya jie
..............page:510-513
xian bing du zai ti yan jiu jin zhan yu zhan wang
wei fang ; huang zuo
..............page:506-509
Clinical analysis of 20 cases of chordomas in the skull base
WEI Rui;JIANG Weixi;WANG Longyun;LIAO Yuping
..............page:501-503
Patient-specific risk factors of chemotherapy-induced neutropenia
DONG Wenchuan;LIU Pingping;REN Xiuhong
..............page:495-497
The effect evaluation on measuring quality of life in patients with liver cancer by SF-36 scale
WAN Chonghua;FANG Jiqian;TANG Xueliang;ZHANG Canzhen;LU Yubo;MENG Qiong;GAO Li
..............page:492-494
Factors predicting survival in patients with intermediate-advanced hepatocellular carcinoma
ZHANG Baihong;LING Changquan;YU Chaoqin;FENG Yinglu
..............page:484-487
Inhibition of endothelial cell migration by transient transfection of Arresten gene
XIONG Jun;SONG Zifang;LU Xin;HU Qinggang;QU Xincai;ZHENG Qichang
..............page:420-422
Enhanced expression of peroxisome proliferator-activated receptor γ in liver cancer
Guo Minglei;Li Jingjun;LI Hongnian;WAN Da fang;Gu Jianren
..............page:413-415
Cancer epidemiology study on diet, gene and their interactions
YUAN Jianmin
..............page:409-412
The loss of heterozygosity(LOH) on chromosome 3 in the DNA samples from human ovarian cancer
XU Jun;LIN Xiao;LI Hong;SHI Lihong;SUN Lei;JIANG Rongmei
..............page:478-480,483
Clinical significance of Syk gene mRNA expression in invasive breast carcinoma tissue
QI Yixin;HU Jie;SONG Zhenchuan;DONG Qing;SHAN Baoen
..............page:475-477
The pathological changes after preoperative chemotherapy and its prognostic value in non-small cell lung cancer
AI Xinghao;LU Shun;CHEN Gang;JI Hao;YU Yongfeng;LIAO Meilin
..............page:466-470
Study on detecting overexpression of HER2 and HER1 in NSCLC and their clinical significance
WU Shuhua;JIANG Shaoqing;DUAN Guangjun;HU Yunzhu;HU Huacheng
..............page:462-465
Epidermal growth factor receptor mutations in Chinese patients with non-small cell lung cancer
ZHOU Caicun;ZHAO Yinmin;TANG Liang;GAO Wen
..............page:458-461
Exploration on the relationship between MTHFR(5,10-methylenetetrahydrofolate reductase) gene polymorphisms and the risk of primary liver cancer
MU Lina;Cao Wei;WEI Guorong;CHEN Chuanwei;DING Baoguo;ZHOU Xuefu;CHANG Jun;CAI Lin;JIANG Qingwu;ZHANG Zuofeng;YU Shunzhang
..............page:453-457
Study on the effects of CD44 molecules in peritoneal transplantation of gastric cancer cells in vitro
DING Youcheng;ZHAO Zhongxing;WANG Liwei;ZHANG Hui;LU Aiguo;YIN hua
..............page:450-452
The efficiency of MACS (magnetic activated cell sorting) enrichment on disseminated tumor cells in bone marrow of gastric cancer
WANG Guiying;WANG Shijie;LI Yong;YU Yueming;TIAN Ziqiang;SONG Zhenchuan
..............page:445-449
Anti-tumor therapy based on the mouse mesenchymal stem cells genetically engineered to express soluble sFlt-1
HU Min;LI Qiu;TENG Hong;WANG Rui;ZHANG Xiaowei;WU Yang;LUO Yan;KAN Bing;WEI Yuquan;YANG Jinliang
..............page:434-438
Somatic mutations on exon 3 of the β-catenin gene in human hepatocellular carcinoma
YOU Haiyan;YAO Genfu;YU Bin;ZHANG Haitao;YU Yanjun;XIE Li;QIN Wenxin
..............page:430-433,444
Quantitative analysis of the circulating DNA in C57BL/6 mice
CHEN Hao;CHEN Zhen;TU Hong;LIU Luming;YU Erxing
..............page:427-429
Influence of celecoxib, a selective COX-2 inhibitor, on the expressions of COX-2, VEGF, MMP-2 and MVD in Lewis lung carcinoma tissue
YU Wanjun;XIU Qingyu;LI Bing;SHI Zhaoquan;FANG Zheng;HUANG Hai
..............page:423-426